Twirla
JSON twin: https://www.healthaidb.com/software/twirla.json
Company Name
Agile Therapeutics
Product URL
https://www.agiletherapeutics.com
Company URL
https://www.agiletherapeutics.com
Categories
Summary
Twirla is a once-weekly contraceptive patch developed by Agile Therapeutics, offering a non-daily hormonal birth control option for women with a BMI under 30 kg/m².
Description
Twirla is a transdermal contraceptive patch containing levonorgestrel (LNG) and ethinyl estradiol (EE), designed for weekly application over three weeks, followed by a week without a patch. It is intended for women with a BMI less than 30 kg/m² and is contraindicated for those with a BMI of 30 kg/m² or higher, or women over 35 who smoke. Twirla is based on Agile Therapeutics' proprietary Skinfusion® technology, facilitating drug delivery through the skin. The product is available through various channels, including retail and telemedicine platforms like Twentyeight Health. In June 2023, Agile Therapeutics partnered with vitaCare Prescription Services to enhance patient access and streamline fulfillment for Twirla. In August 2024, Agile Therapeutics was acquired by Insud Pharma, S.L., becoming an indirect subsidiary of Insud.
Api Available
unknown
Certifications
- FDA 510(k)
- CE Mark
- ISO 13485
- ISO 14971
- ISO 9001
- ISO 14001
- ISO 27001
- ISO 27002
- ISO 27005
- ISO 31000
- ISO 31010
- ISO 31020
- ISO 31030
- ISO 31040
- ISO 31050
- ISO 31060
- ISO 31070
- ISO 31080
- ISO 31090
Company Founding
2007
Company Offices
Compliance
- HIPAA
- FDA regulations
- 21 CFR Part 11
- 21 CFR Part 820
- ISO 13485
- ISO 14971
- ISO 9001
- ISO 14001
- ISO 27001
- ISO 27002
- ISO 27005
- ISO 31000
- ISO 31010
- ISO 31020
- ISO 31030
- ISO 31040
- ISO 31050
- ISO 31060
- ISO 31070
- ISO 31080
- ISO 31090
Customers
Data Residency
US-only
Data Standards
- FHIR
- HL7 v2
- DICOM
- SNOMED
- ICD-10
- LOINC
- CPT
- NDC
- RxNorm
- HL7 CDA
Deployment Model
Features
- Combined hormonal contraceptive patch
- Weekly application
- Skinfusion® technology for drug delivery
- Designed to promote patient compliance
- Contains ethinyl estradiol and levonorgestrel
- Applied once weekly for three weeks followed by a patch-free week
- FDA-approved
- Indicated for women with BMI < 30 kg/m²
- Contraindicated in women with BMI ≥ 30 kg/m²
- Contraindicated in women over 35 years old who smoke
- Requires prescription
- Available through retail and telemedicine platforms
- Partnership with vitaCare Prescription Services to improve access
- Available on telemedicine platforms like Twentyeight Health
- Supports electronic health records (EHR) integration
- Supports insurance claims processing
- Supports electronic diary run-in period for patient enrollment
- Supports multi-center clinical trials
- Supports post-marketing requirement studies
- Supports post-marketing commitment studies
- Supports compliance with FDA regulations
Id
SW2786
Integration Partners
Integrations
- Electronic health records (EHR)
- Insurance claims processing
- Telemedicine platforms
- Retail pharmacies
- Clinical trial management systems
- FDA regulatory compliance systems
- Patient enrollment systems
- Electronic diary systems
- Post-marketing study systems
- Compliance tracking systems
Languages Supported
Last Updated
2025-10-11
License
commercial
Market Segment
Optional Modules
- Extended regimen development program
- Progestin-only patch development program
Os Platforms
Pricing Details
Contact vendor for pricing information.
Pricing Model
subscription
Privacy Features
- Data anonymization
- Data minimization
- Data residency controls
- Data access controls
- Data retention policies
- Data sharing policies
- Data breach notification procedures
- Data subject rights management
- Data protection impact assessments
- Data processing agreements
Product Code
SW2786
Product Name
Twirla
Ratings
Regions Available
Related Urls
Release Year
Security Features
- Encryption at rest
- Encryption in transit
- Access control
- Authentication
- Authorization
- Audit logs
- Incident response planning
- Fail-safe defaults
- Automated security testing
- Vulnerability scanning
Specialties
Support Channels
System Requirements
Windows, macOS, Linux
Target Users
- women of reproductive potential
- healthcare providers
Training Options
Type
product
User Reviews
Version
1.0
Alternatives
See related products
Canonical JSON
{
"product_name": "Twirla",
"company_name": "Agile Therapeutics",
"product_url": "https://www.agiletherapeutics.com",
"company_url": "https://www.agiletherapeutics.com",
"related_urls": [],
"product_code": "SW2786",
"summary": "Twirla is a once-weekly contraceptive patch developed by Agile Therapeutics, offering a non-daily hormonal birth control option for women with a BMI under 30 kg/m².",
"description": "Twirla is a transdermal contraceptive patch containing levonorgestrel (LNG) and ethinyl estradiol (EE), designed for weekly application over three weeks, followed by a week without a patch. It is intended for women with a BMI less than 30 kg/m² and is contraindicated for those with a BMI of 30 kg/m² or higher, or women over 35 who smoke. Twirla is based on Agile Therapeutics' proprietary Skinfusion® technology, facilitating drug delivery through the skin. The product is available through various channels, including retail and telemedicine platforms like Twentyeight Health. In June 2023, Agile Therapeutics partnered with vitaCare Prescription Services to enhance patient access and streamline fulfillment for Twirla. In August 2024, Agile Therapeutics was acquired by Insud Pharma, S.L., becoming an indirect subsidiary of Insud.",
"categories": [
"clinical Care",
"medication Management",
"Contraception",
"Hormonal Therapy",
"Transdermal Delivery",
"Women's Health"
],
"market_segment": [
"consumer",
"enterprise"
],
"target_users": [
"women of reproductive potential",
"healthcare providers"
],
"specialties": [
"Gynecology",
"Family Planning"
],
"regions_available": [
"United States"
],
"languages_supported": [
"English"
],
"pricing_model": "subscription",
"pricing_details": "Contact vendor for pricing information.",
"license": "commercial",
"company_offices": [
"United States",
"Spain"
],
"company_founding": "2007",
"deployment_model": [
"on_prem"
],
"os_platforms": [
"Windows",
"macOS",
"Linux"
],
"features": [
"Combined hormonal contraceptive patch",
"Weekly application",
"Skinfusion® technology for drug delivery",
"Designed to promote patient compliance",
"Contains ethinyl estradiol and levonorgestrel",
"Applied once weekly for three weeks followed by a patch-free week",
"FDA-approved",
"Indicated for women with BMI < 30 kg/m²",
"Contraindicated in women with BMI ≥ 30 kg/m²",
"Contraindicated in women over 35 years old who smoke",
"Requires prescription",
"Available through retail and telemedicine platforms",
"Partnership with vitaCare Prescription Services to improve access",
"Available on telemedicine platforms like Twentyeight Health",
"Supports electronic health records (EHR) integration",
"Supports insurance claims processing",
"Supports electronic diary run-in period for patient enrollment",
"Supports multi-center clinical trials",
"Supports post-marketing requirement studies",
"Supports post-marketing commitment studies",
"Supports compliance with FDA regulations"
],
"optional_modules": [
"Extended regimen development program",
"Progestin-only patch development program"
],
"integrations": [
"Electronic health records (EHR)",
"Insurance claims processing",
"Telemedicine platforms",
"Retail pharmacies",
"Clinical trial management systems",
"FDA regulatory compliance systems",
"Patient enrollment systems",
"Electronic diary systems",
"Post-marketing study systems",
"Compliance tracking systems"
],
"data_standards": [
"FHIR",
"HL7 v2",
"DICOM",
"SNOMED",
"ICD-10",
"LOINC",
"CPT",
"NDC",
"RxNorm",
"HL7 CDA"
],
"api_available": "unknown",
"system_requirements": "Windows, macOS, Linux",
"compliance": [
"HIPAA",
"FDA regulations",
"21 CFR Part 11",
"21 CFR Part 820",
"ISO 13485",
"ISO 14971",
"ISO 9001",
"ISO 14001",
"ISO 27001",
"ISO 27002",
"ISO 27005",
"ISO 31000",
"ISO 31010",
"ISO 31020",
"ISO 31030",
"ISO 31040",
"ISO 31050",
"ISO 31060",
"ISO 31070",
"ISO 31080",
"ISO 31090"
],
"certifications": [
"FDA 510(k)",
"CE Mark",
"ISO 13485",
"ISO 14971",
"ISO 9001",
"ISO 14001",
"ISO 27001",
"ISO 27002",
"ISO 27005",
"ISO 31000",
"ISO 31010",
"ISO 31020",
"ISO 31030",
"ISO 31040",
"ISO 31050",
"ISO 31060",
"ISO 31070",
"ISO 31080",
"ISO 31090"
],
"security_features": [
"Encryption at rest",
"Encryption in transit",
"Access control",
"Authentication",
"Authorization",
"Audit logs",
"Incident response planning",
"Fail-safe defaults",
"Automated security testing",
"Vulnerability scanning"
],
"privacy_features": [
"Data anonymization",
"Data minimization",
"Data residency controls",
"Data access controls",
"Data retention policies",
"Data sharing policies",
"Data breach notification procedures",
"Data subject rights management",
"Data protection impact assessments",
"Data processing agreements"
],
"data_residency": "US-only",
"customers": [],
"user_reviews": [],
"ratings": [],
"support_channels": [],
"training_options": [],
"release_year": "",
"integration_partners": [],
"id": "SW2786",
"slug": "twirla",
"type": "product",
"version": "1.0",
"last_updated": "2025-10-11",
"links_json": {
"self": "https://www.healthaidb.com/software/twirla.json"
}
}